Carbohydrate Fluids for Postoperative Nausea and Vomiting
(PONV Trial)
Trial Summary
What is the purpose of this trial?
This study is a prospective randomized clinical controlled trial testing the effects of pre-operative \>50 g pre-operative carbohydrate fluids (apple juice) on a patient's post-operative nausea and vomiting (PONV) incidence and intensity. Optimizing fluid therapy in the peri-operative setting has been proven to improve patient outcomes and reduce complications and length of hospital stay. Based on practice guidelines under the American Society of Anesthesiologists, pre-operative hydration with complex carbohydrate drinks is safe and should be encouraged as it helps with improving metabolism to an anabolic state, decreases insulin resistance, reduces anxiety, and reduces PONV. While pre-operative carbohydrate (CHO) fluids have already been studied and adopted by other surgical specialities (Vascular, General Surgery, Orthopaedics, etc.), this has not yet been studied in oral and maxillofacial surgery, especially at Boston Medical Center (BMC). During surgery, each participant will undergo our current Enhanced Recovery After Surgery "ERAS" protocol, which includes general anesthesia using inhalational gas, judicious IV fluids, intra-operative steroid and ondansetron (anti-emetic), use of 0.5% bupivacaine local anesthesia per quadrant at surgery end time, use of a throat pack, and orogastric/nasogastric (OG/NG) tube suctioning prior to extubation to minimize ingestion of blood. Pain and anxiety medications prior to and during surgery include 2 mg midazolam, fentanyl per anesthesia, toradol, and dexmedetomidine. Having this protocol will help minimize confounding variables that could affect the primary outcome-- incidence and severity of PONV. The objectives for this research are: * To evaluate if pre-operative clear CHO help reduce incidence and intensity of PONV. * To assess if pre-operative clear carbohydrate fluids affect length of hospital stay * To determine if pre-operative CHO reduce patient's pre-/post-operative anxiety * To compare the amount/number of opioids and anti-emetics needed post-operatively between the two groups * To compare ability for patients to return to PO hydration via the amount of fluid ingestion (mL) vs. if they need IV fluids due to decreased PO intake/inability to tolerate PO fluids * To evaluate if patient Apfel score is also a strong indicator for incidence/severity of PONV
Will I have to stop taking my current medications?
The trial information does not specify if you need to stop taking your current medications. However, if you have a history of gastroesophageal reflux disease, motion sickness, or diabetes, you may not be eligible to participate.
What data supports the effectiveness of the treatment carbohydrate drink for reducing postoperative nausea and vomiting?
Is it safe to use carbohydrate fluids for postoperative nausea and vomiting?
How does the carbohydrate drink treatment differ from other treatments for postoperative nausea and vomiting?
The carbohydrate drink is unique because it is given before surgery to improve the body's metabolic state, which may help reduce nausea and vomiting after surgery. Unlike other treatments that are often given after symptoms appear, this drink is used proactively to potentially prevent these symptoms.13456
Research Team
Angeline Nguyen, DMD
Principal Investigator
Boston Medical Center, Oral and Maxillofacial Surgery
Eligibility Criteria
This trial is for patients undergoing oral and maxillofacial surgery at Boston Medical Center who can safely consume a carbohydrate drink before their operation. It's not specified who cannot join, but typically those with allergies to the study materials or conflicting medical conditions would be excluded.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pre-operative
Participants receive pre-operative carbohydrate fluids or undergo fasting before surgery
Surgery and Immediate Post-operative
Participants undergo surgery with the ERAS protocol and are monitored for PONV intensity and incidence
Follow-up
Participants are monitored for safety and effectiveness after treatment, including PONV assessment and hospital discharge
Treatment Details
Interventions
- Carbohydrate drink
Find a Clinic Near You
Who Is Running the Clinical Trial?
Boston Medical Center
Lead Sponsor